- Home
- CRTO vs BBNX Comparison
CRTO vs BBNX Comparison
Compare CRTO & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRTO | BBNX |
|---|---|---|
| Founded | 2005 | 2015 |
| Country | France | United States |
| Employees | N/A | 423 |
| Industry | Advertising | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 980.6M | 493.1M |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | CRTO | BBNX |
|---|---|---|
| Price | $18.41 | $10.01 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 9 |
| Target Price | ★ $35.90 | $26.22 |
| AVG Volume (30 Days) | 252.2K | ★ 1.0M |
| Earning Date | 05-01-2026 | 04-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.95 | N/A |
| EPS | ★ 2.64 | N/A |
| Revenue | ★ $2,296,692,000.00 | N/A |
| Revenue This Year | N/A | $34.99 |
| Revenue Next Year | $5.62 | $34.47 |
| P/E Ratio | $6.80 | ★ N/A |
| Revenue Growth | ★ 27.65 | N/A |
| 52 Week Low | $16.15 | $8.89 |
| 52 Week High | $35.10 | $32.71 |
Technical Indicators
Market Signals| Indicator | CRTO | BBNX |
|---|---|---|
| Relative Strength Index (RSI) | 53.97 | 32.79 |
| Support Level | $17.83 | $9.91 |
| Resistance Level | $19.79 | $11.92 |
| Average True Range (ATR) | 0.73 | 0.67 |
| MACD | 0.07 | 0.12 |
| Stochastic Oscillator | 73.70 | 25.88 |
Price Performance
Historical ComparisonAbout CRTO Criteo S.A.
Criteo SA is an ad-tech company in the digital advertising market. Its technology, allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. It has two reportable segments: Retail Media and Performance Media. The firm also provides technology allowing retailers to effectively manage their ad inventories and improve yield optimization.
About BBNX Beta Bionics Inc.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.